EssilorLuxottica Unveils Robust Scientific Agenda at WCPOS V 2024 in Malaysia, Reinforcing Global Commitment to Myopia Management
EssilorLuxottica Unveils Robust Scientific Agenda at WCPOS V 2024 in Malaysia, Reinforcing Global Commitment to Myopia Management
Charenton-le-Pont, France (July 24, 2024) – As an exclusive diamond sponsor, EssilorLuxottica's contribution to the 5th World Congress of Paediatric Ophthalmology and Strabismus (WCPOS V) reaffirmed the Group's long-term commitment to advancing myopia management globally, through a comprehensive scientific program, collaboration with key experts, and new scientific and clinical research. In Kuala Lumpur, Malaysia, connecting with over 1,400 international delegates from 70 countries on July 11-13, the Group presented latest research on Essilor Stellest lenses at its satellite sessions with leading international experts. Both sessions were moderated by Prof. Dominique Bremond-Gignac (France).
作爲獨家金剛石贊助商，EssilorLuxottica在第五屆兒科眼科和斜視世界大會(WCPOS V)上的貢獻通過全面的科學計劃、與關鍵專家的合作、新的科學和臨床研究，再次確認了該集團全球推進遠視管理的長期承諾。在馬來西亞的吉隆坡，與來自70個國家的1400多名國際代表建立聯繫，在7月11-13日的衛星會議上與領先的國際專家一起展示了Essilor Stellest鏡片的最新研究。兩個會議都由法國的Dominique Bremond-Gignac教授主持。
A key focus of the Group's presence at WCPOS V was on the five-year clinical trial results of Essilor Stellest lenses and latest strategies in combination with low-dose atropine.
該集團在WCPOS V大會上的關鍵焦點是Essilor Stellest鏡片的五年臨床試驗結果以及與低劑量阿托品的最新綜合策略。
The Group's satellite sessions featured presentations by Prof. Mark Bullimore (USA) on approaches and models for evaluating efficacy in myopia control clinical trials, and insights from Olga Prenat, Global Head of Medical & Professional Affairs and Adeline Yang, Head of Medical and Professional Affairs, SEAK, EssilorLuxottica, on the outcomes of the five-year clinical trial and latest research on Essilor Stellest lenses. Prof. Aldo Vagge (Italy) introduced findings from an independent retrospective study on Essilor Stellest lenses combined with low-dose atropine1. Dr. Bryan Sim (Singapore) also unveiled results from the first independent global prospective study on low-dose atropine combined with Essilor Stellest lenses across various age groups starting from 6 years old and above in Singaporean children 2.
集團的衛星會議特色板塊來自美國的Mark Bullimore教授，就評估遠視控制臨床試驗的效力方法和模型提出了不同的方法與模型，還有Olga Prenat醫學和專業事務總部主管和Adeline Yang，東南亞地區醫學與專業事務主管ESSILOR LUXOTTICA，關於五年臨床試驗和Essilor Stellest鏡片最新研究的成果。意大利的Aldo Vagge教授介紹了一項關於Essilor Stellest鏡片結合低劑量阿托品的獨立後瞻性研究結果，新加坡的Bryan Sim醫生還介紹了關於遠視控制的首個全球獨立前瞻性研究結果，該研究跨越不同年齡組、從6歲及以上的新加坡兒童並使用高度非球面微透鏡目標(HALT)眼鏡和低劑量阿托品。
The sessions also covered topics such as emmetropic eye growth with Essilor Stellest lenses by Prof. Mark Bullimore and outdoor environmental factors in myopia prevention, emphasizing the role of sun protection with myopia management by Prof. Saw Seang Mei (Singapore)3. She recommended that children engage in outdoor activities for at least 2-3 hours daily and at least 14-21 hours weekly. Additionally, Olga Prenat and Adeline Yang introduced Essilor Stellest lenses with sun tints, the extended range of Essilor Stellest lenses, and highlighted the outcomes from the recent studies showing no impact on astigmatism4 and effects on the choroidal thickness after three years of use of Essilor Stellest lenses5.
這些會議還涉及emmetropic eye growth with Essilor Stellest lenses話題，由Mark Bullimore教授主持，以及在遠視預防中的戶外環境因素，強調陽光保護與遠視管理的作用，由Saw Seang Mei教授主持。她建議孩子每天至少外出活動2-3小時，每週至少14-21小時。此外，Olga Prenat和Adeline Yang介紹了帶有太陽色調的Essilor Stellest鏡片、擴展的Essilor Stellest鏡片系列，並強調最近研究的結果，顯示Essilor Stellest鏡片對散光沒有影響，並對使用Essilor Stellest鏡片三年後脈絡膜厚度有影響。
"We were pleased to continue our collaboration with the World Society of Paediatric Ophthalmology and Strabismus. WCPOS V provided a unique platform to present the latest evidence-based research, highlight the long-term efficacy and performance of Essilor Stellest lenses to paediatric ophthalmologists and engage with them on the future of myopia management and patient benefits," said Olga Prenat, Head of Medical & Professional Affairs at EssilorLuxottica. "The enthusiastic response from delegates underscores the significance of our collective efforts in advancing global myopia management."
“我們很高興能夠繼續與世界兒科眼科和斜視協會合作，WCPOS V提供了一個獨特的平台，向兒科眼科醫生展示最新的基於證據的研究，突出Essilor Stellest鏡片的長期療效和性能，以及展望我們在推進全球遠視管理和患者的福利方面的未來與醫生們進行交流”，EssilorLuxottica的醫學和專業事務負責人Olga Prenat表示。“代表們的熱情回應強調了我們在推進全球遠視管理的集體努力的重要性。”
Footnotes
Essilor Stellest lenses are currently not available in all countries.
腳註
目前，Essilor Stellest鏡片並未在所有國家出售。
1. Aldo Vagge, Antonio Frattolillo, Paolo Nucci, Francesco Samassa, Guido Barosco, Emilio Rapizzi, Michele Iester, Carlo Enrico Traverso; Highly Aspherical Lenslet Target (HALT) technology in combination with low-dose atropine to control myopia progression. Invest. Ophthalmol. Vis. Sci. 2024;65(7):2739.
2. B Sim; H M Htoon; Loh KL; R Sim; C Lam; Maithily B; P Chan, A Chia. Combination therapy with Highly Aspherical Lenslet Target (HALT) spectacles and atropine eyedrops compared with atropine monotherapy for myopia control in Singaporean children
3. Carla Lanca, Aaron Teo, Ananthan Vivagandan, Hla M. Htoon, Raymond P. Najjar, Daniel P. Spiegel, Suan-Hui Pu, Seang-Mei Saw; The Effects of Different Outdoor Environments, Sunglasses and Hats on Light Levels: Implications for Myopia Prevention. Trans. Vis. Sci. Tech. 2019;8(4):7. .
4. Jinhua Bao, Yingying Huang, Xue Li, Ee Woon Lim, Bjorn Drobe, Hao Chen; Two-year changes in cylinder power in myopic children wearing spectacle lenses with highly aspherical lenslets and single-vision spectacle lenses. Invest. Ophthalmol. Vis. Sci. 2024;65(7):160.
5. Huang, Y., Li, X., Zhuo, Z. et al. Effect of spectacle lenses with aspherical lenslets on choroidal thickness in myopic children: a 3-year follow-up study. Eye and Vis 11, 16 (2024).
1. Aldo Vagge, Antonio Frattolillo, Paolo Nucci, Francesco Samassa, Guido Barosco, Emilio Rapizzi, Michele Iester, Carlo Enrico Traverso; Highly Aspherical Lenslet Target (HALT) technology in combination with low-dose atropine to control myopia progression. Invest. Ophthalmol. Vis. Sci. 2024;65(7):2739。
2. b Sim; H m Htoon; Loh KL; R Sim; C Lam; Maithily B; P Chan, A Chia. Combination therapy with Highly Aspherical Lenslet Target (HALT) spectacles and atropine eyedrops compared with atropine monotherapy for myopia control in Singaporean children
3. Carla Lanca, Aaron Teo, Ananthan Vivagandan, Hla m. Htoon, Raymond P. Najjar, Daniel P. Spiegel, Suan-Hui Pu, Seang-Mei Saw; The Effects of Different Outdoor Environments, Sunglasses and Hats on Light Levels: Implications for Myopia Prevention. Trans. Vis. Sci. Tech. 2019;8(4):7. 。
4. Jinhua Bao, Yingying Huang, Xue Li, Ee Woon Lim, Bjorn Drobe, Hao Chen; Two-year changes in cylinder power in myopic children wearing spectacle lenses with highly aspherical lenslets and single-vision spectacle lenses. Invest. Ophthalmol. Vis. Sci. 2024;65(7):160。
5. Huang, Y., Li, X., Zhuo, Z. et al. Effect of spectacle lenses with aspherical lenslets on choroidal thickness in myopic children: a 3-year follow-up study. Eye and Vis 11, 16 (2024).
DOWNLOAD THE PRESS RELEASE
下載新聞稿
譯文內容由第三人軟體翻譯。